Paris-based Curium, a world leader in nuclear medicine, has entered into a strategic partnership with PDRadiopharma Inc,...
Japan's TERUMO Asia Holdings has launched its “Terumo Asia Skill Lab” at its Asia-Pa...
Olympus Corporation, a global medtech company headquartered in Japan, has announced the launch of VISERA S, the all-in-o...
US-based Boston Scientific Corporation has received Pharmaceuticals and Medical Device Agency (PMDA) approval in&nb...
Nxera Pharma, formerly known as Sosei Group or Sosei Heptares, has received approval from the Ministry of Health, Labour...
Japanese pharma firm Takeda has awarded JPY 4.6 billion (approximately $32 million) to five new partners in the field of...
Japan's Shimadzu Corporation has established a subsidiary in Mexico and has begun its activities. To date, in Mexico, an...
US-based iRhythm Technologies, Inc., a leading digital healthcare company focused on creating trusted solutions that det...
Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...
Osivax, a FRance-based biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly...
Antibody Engineering & Therapeutics Asia: Date: October 21 – 23, 2024Location: The Westin Miyako Kyoto Antib...
Takara Bio USA, Inc., a wholly owned subsidiary of Japan-based Takara Bio Inc., has announced the launch of the SmartChi...
US-based Rigel Pharmaceuticals, Inc., a commercial stage biotechnology company focused on hematologic disorders and canc...
Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab in Japan, has ...
The Biomedical Division of PHC Corporation, based in Japan, will present a prototype of its new cell expansion syst...
Japan’s biotech sector is a landscape rife with opportunity, yet also a complex market that requires a deep unders...
Japan has a robust drug discovery capability, having developed an interleukin-6 inhibitor, a programmed cell death prote...
Japan's biotech ecosystem is at a pivotal moment, characterised by both challenges and opportunities. Despite a rich his...
